Chapel Hill, NC, United States of America

Dietlinde-Maria Wolf

This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: University of Miami. Active years: 2016-2021.

USPTO Granted Patents = 2 

% Patents Active = 100.0


 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Location History:

  • Key Biscayne, FL (US) (2016)
  • Chapel Hill, NC (US) (2021)

Company Filing History:


Years Active: 2016-2021

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Dietlinde-Maria Wolf: Innovator in Immunology

Introduction

Dietlinde-Maria Wolf is a prominent inventor based in Chapel Hill, NC (US). She has made significant contributions to the field of immunology, particularly in the area of T regulatory cells. With a total of 2 patents, her work has the potential to impact therapeutic strategies for immune modulation.

Latest Patents

Wolf's latest patents include a method for in vivo expansion of T regulatory cells. This method involves compositions specific for TNF-receptor superfamily member 25 (TNFRSF25, DR3), which modulate the immune response by regulating T regulatory cells. This innovative approach could lead to advancements in treating various immune-related conditions.

Career Highlights

Dietlinde-Maria Wolf is affiliated with the University of Miami, where she continues her research and development in immunology. Her work has garnered attention for its potential applications in clinical settings, particularly in enhancing immune responses.

Collaborations

Wolf collaborates with notable colleagues, including Eckhard R Podack and Taylor H Schreiber. These partnerships enhance her research capabilities and contribute to the advancement of knowledge in the field.

Conclusion

Dietlinde-Maria Wolf is a key figure in the field of immunology, with her innovative patents paving the way for future research and therapeutic applications. Her contributions are vital to understanding and manipulating immune responses for better health outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…